title: Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect.
abstract: BACKGROUND
  Glomuvenous malformation (GVM) ("familial glomangioma") is a localised cutaneous vascular lesion histologically characterised by abnormal smooth muscle-like "glomus cells" in the walls of distended endothelium lined channels. Inheritable GVM has been linked to chromosome 1p21-22 and is caused by truncating mutations in glomulin. A double hit mutation was identified in one lesion. This finding suggests that GVM results from complete localised loss of function and explains the paradominant mode of inheritance.
  
  
  OBJECTIVE
  To report on the identification of a mutation in glomulin in 23 additional families with GVM.
  
  
  RESULTS
  Three mutations are new; the others have been described previously. Among the 17 different inherited mutations in glomulin known up to now in 43 families, the 157delAAGAA mutation is the most common and was present in 21 families (48.8%). Mutation 108C-->A was found in five families (11.8%), and the mutations 554delA+556delCCT and 1179delCAA were present together in two families (4.7% each). Polymorphic markers suggested a founder effect for all four mutations.
  
  
  CONCLUSIONS
  Screening for these mutations should lead to a genetic diagnosis in about 70% of patients with inherited GVM. So far, a mutation in glomulin has been found in all GVM families tested, thus demonstrating locus homogeneity.
authors.affiliation: Laboratory of Human Molecular Genetics, Christian de Duve Institute of Cellular Pathology and Université catholique de Louvain, Brussels, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Brouillard
authors.forename: M
authors.initials: M
authors.lastname: Ghassibé
authors.forename: A
authors.initials: A
authors.lastname: Penington
authors.forename: L M
authors.initials: LM
authors.lastname: Boon
authors.forename: A
authors.initials: A
authors.lastname: Dompmartin
authors.forename: I K
authors.initials: IK
authors.lastname: Temple
authors.forename: M
authors.initials: M
authors.lastname: Cordisco
authors.forename: D
authors.initials: D
authors.lastname: Adams
authors.forename: F
authors.initials: F
authors.lastname: Piette
authors.forename: J I
authors.initials: JI
authors.lastname: Harper
authors.forename: S
authors.initials: S
authors.lastname: Syed
authors.forename: F
authors.initials: F
authors.lastname: Boralevi
authors.forename: A
authors.initials: A
authors.lastname: Taïeb
authors.forename: S
authors.initials: S
authors.lastname: Danda
authors.forename: E
authors.initials: E
authors.lastname: Baselga
authors.forename: O
authors.initials: O
authors.lastname: Enjolras
authors.forename: J B
authors.initials: JB
authors.lastname: Mulliken
authors.forename: M
authors.initials: M
authors.lastname: Vikkula
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics*; D000595:Amino Acid Sequence; D004252:DNA Mutational Analysis; D005260:Female; D018703:Founder Effect; D018095:Germ-Line Mutation; D005918:Glomus Tumor / Q000175:diagnosis / Q000235:genetics*; D006239:Haplotypes; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D010375:Pedigree; D010641:Phenotype; D016415:Sequence Alignment
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C103024:GLMN protein, human